• $32.2M
    Market Cap
  • -7.25%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2026
06/30/2025
06/30/2024
06/30/2023
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-4.7M
-15.16%
-5.5M
+2.06%
-5.4M
-14.94%
-6.4M
+10.50%
Depreciation and Amortization Expense
8,270
+0.01%
8,269
-0.01%
8,270
0.00%
8,270
0.00%
Total Operating Expenses
8.3M
-13.40%
9.6M
+12.63%
8.5M
-4.78%
8.9M
+10.23%
Operating Profit
-8.3M
-13.40%
-9.6M
+12.63%
-8.5M
-4.78%
-8.9M
+10.23%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-49,808
0.00%
-49,808
+5,210.02%
-938
-81.69%
Interest Income and Expense and Net
0
+100.00%
-49,808
0.00%
-49,808
+5,210.02%
-938
-81.69%
Total Nonoperating Income and Expense
87,852
-29.54%
124,679
-43.83%
221,965
-37.46%
354,895
+5,168.63%
Income before Taxes
-8.3M
-13.40%
-9.6M
+12.63%
-8.5M
-4.78%
-8.9M
+10.32%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.2M
-13.19%
-9.5M
+14.14%
-8.3M
-3.43%
-8.6M
+5.94%
Net Income from Continuing Operations Applicable to Common
-8.2M
-13.19%
-9.5M
+14.14%
-8.3M
-3.43%
-8.6M
+5.94%
Basic EPS and Net Income
-0.41
-34.92%
-0.63
-10.00%
-0.70
-5.41%
-0.74
+5.71%
Diluted EPS and Net Income
-0.41
-34.92%
-0.63
-10.00%
-0.70
-5.41%
-0.74
+5.71%
Basic Weighted Average Shares
20.2M
+33.55%
15.1M
+27.34%
11.9M
+2.11%
11.6M
+0.79%
Diluted Weighted Average Shares
20.2M
+33.55%
15.1M
+27.34%
11.9M
+2.11%
11.6M
+0.79%
Balance Sheet
Cash and Cash Equivalents
2.8M
+74.63%
1.6M
-66.65%
4.8M
-41.13%
8.1M
-42.06%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.8M
+74.63%
1.6M
-66.65%
4.8M
-41.13%
8.1M
-42.06%
Total Current Assets
3.2M
+89.30%
1.7M
-66.39%
5.0M
-41.14%
8.4M
-41.42%
Accumulated Depreciation
8.3M
+1.39%
8.2M
+9.87%
7.5M
+11.20%
6.7M
+12.40%
Property and Plant and Equipment and Net
6.4M
-6.33%
6.8M
-9.03%
7.5M
-7.33%
8.1M
-6.76%
Total Long-Term Assets
6.4M
-6.33%
6.8M
-9.03%
7.5M
+52,211.56%
14,361
-66.16%
Total Assets
9.9M
+11.89%
8.8M
-31.18%
12.8M
-24.12%
16.9M
-28.07%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
2.0M
0.00%
2.0M
0.00%
2.0M
N/A
N/A
N/A
Total Current Liabilities
1.2M
-8.86%
1.3M
-3.85%
1.4M
+154.33%
534,250
+29.41%
Total Long-Term Debt
N/A
N/A
N/A
N/A
1.5M
-5.94%
1.6M
+1,582.48%
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
1.2M
-8.86%
1.3M
-3.85%
1.4M
-33.21%
2.0M
+392.75%
Retained Earnings
-157.1M
+5.52%
-148.8M
+6.79%
-139.4M
+6.33%
-131.1M
+7.01%
Total Stockholders Equity
8.7M
+15.50%
7.5M
-34.43%
11.5M
-22.88%
14.9M
-35.60%
Total Shares Outstanding
23.0M
+38.55%
16.6M
+26.34%
13.1M
+12.36%
11.7M
+0.92%
Cash Flow
Cash from Operating Activities
-7.7M
-9.23%
-8.5M
+34.25%
-6.3M
+11.38%
-5.7M
-3.75%
Capital Expenditures
84,317
+48.02%
56,964
-63.62%
156,560
+3.20%
151,712
-53.23%
Cash from Investing Activities
-84,317
+48.02%
-56,964
-63.62%
-156,560
+3.20%
-151,712
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.0M
+70.23%
5.3M
+69.76%
3.1M
+3,391.59%
-94,788
-59.62%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-87.91%
+0.51%
-87.47%
+56.72%
-55.81%
+31.25%
-42.52%
+40.99%
Return on Equity
-101.46%
+1.72%
-99.75%
+58.33%
-63.00%
+39.18%
-45.27%
+47.95%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.66
+107.72%
1.28
-65.04%
3.66
-76.86%
15.81
-54.73%
Cash Ratio
2.35
+91.62%
1.22
-65.32%
3.53
-76.85%
15.25
-55.23%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
0.31
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
0.27
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow